BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31261510)

  • 1. Integrative cancer treatment may have a survival benefit in patients with lung cancer: A retrospective cohort study from an integrative cancer center in Korea.
    Bae K; Kim E; Kong JS; Kim J; Park SJ; Jun HJ; Cho CK; Kim MK; Yoo HS
    Medicine (Baltimore); 2019 Jun; 98(26):e16048. PubMed ID: 31261510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Chemotherapy Integrated With Traditional Korean Medicine in Patients With Metastatic Pancreatic Cancer: A Single-Center Retrospective Study.
    Kim EH; Yoon JH; Yoon SS; Lee JY; Yoon SW
    Integr Cancer Ther; 2020; 19():1534735420983457. PubMed ID: 33349074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of anticancer traditional Korean medicine treatment on the survival in patients with lung, breast, gastric, colorectal, hepatic, uterine, or ovarian cancer: A prospective cohort study protocol.
    Bae K; Kim E; Choi JJ; Kim MK; Yoo HS
    Medicine (Baltimore); 2018 Oct; 97(41):e12444. PubMed ID: 30313034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usage patterns and adverse experiences in traditional Korean medicine: results of a survey in South Korea.
    Shin HK; Jeong SJ; Huang DS; Kang BK; Lee MS
    BMC Complement Altern Med; 2013 Dec; 13():340. PubMed ID: 24289266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Rhus verniciflua stokes extracts in patients with previously treated advanced non-small cell lung cancer.
    Cheon SH; Kim KS; Kim S; Jung HS; Choi WC; Eo WK
    Forsch Komplementmed; 2011; 18(2):77-83. PubMed ID: 21576976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.
    Segev Y; Lavie O; Stein N; Saliba W; Samuels N; Shalabna E; Raz OG; Schiff E; Ben-Arye E
    Support Care Cancer; 2021 Jul; 29(7):4055-4064. PubMed ID: 33404816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study.
    Ha SJ; Kwag E; Kim S; Park JH; Park SJ; Yoo HS
    Integr Cancer Ther; 2023; 22():15347354231154267. PubMed ID: 37615075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in prognosis factors in patients with lung cancer: A nationwide retrospective cohort study in Korea.
    Huh Y; Sohn YJ; Kim HR; Chun H; Kim HJ; Son KY
    PLoS One; 2024; 19(5):e0300389. PubMed ID: 38728284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities.
    Bilfinger T; Keresztes R; Albano D; Nemesure B
    Med Sci Monit; 2016 Jul; 22():2589-94. PubMed ID: 27442604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.
    Naylor KL; Kim SJ; McArthur E; Garg AX; McCallum MK; Knoll GA
    Am J Kidney Dis; 2019 Jun; 73(6):765-776. PubMed ID: 30738630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative traditional Korean medicine treatment for children with idiopathic short stature: A STROBE-compliant case series.
    Kim YJ; Lee SH; Jang S; Lee JY; Chang GT; Lee B
    Medicine (Baltimore); 2022 Jul; 101(28):e29754. PubMed ID: 35839047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration.
    Sullivan DR; Chan B; Lapidus JA; Ganzini L; Hansen L; Carney PA; Fromme EK; Marino M; Golden SE; Vranas KC; Slatore CG
    JAMA Oncol; 2019 Dec; 5(12):1702-1709. PubMed ID: 31536133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a 'Watch and Wait' Approach for Chemotherapy in Patients with Newly Diagnosed Advanced Non-small Cell Lung Cancer from a Diverse Community Population.
    Noonan K; Tong KM; Laskin J; Zheng YY; Melosky B; Sun S; Murray N; Ho C
    Clin Oncol (R Coll Radiol); 2015 Sep; 27(9):505-13. PubMed ID: 26095646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
    Duruisseaux M; Martínez-Cardús A; Calleja-Cervantes ME; Moran S; Castro de Moura M; Davalos V; Piñeyro D; Sanchez-Cespedes M; Girard N; Brevet M; Giroux-Leprieur E; Dumenil C; Pradotto M; Bironzo P; Capelletto E; Novello S; Cortot A; Copin MC; Karachaliou N; Gonzalez-Cao M; Peralta S; Montuenga LM; Gil-Bazo I; Baraibar I; Lozano MD; Varela M; Ruffinelli JC; Palmero R; Nadal E; Moran T; Perez L; Ramos I; Xiao Q; Fernandez AF; Fraga MF; Gut M; Gut I; Teixidó C; Vilariño N; Prat A; Reguart N; Benito A; Garrido P; Barragan I; Emile JF; Rosell R; Brambilla E; Esteller M
    Lancet Respir Med; 2018 Oct; 6(10):771-781. PubMed ID: 30100403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Targeted Therapy on the Survival of Patients With Advanced-Stage Non-small Cell Lung Cancer in Oncosalud - AUNA.
    Aguilar A; Mas L; Enríquez D; Vallejos C; Gutarra R; Flores CJ
    Cancer Control; 2022; 29():10732748211068637. PubMed ID: 35030060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
    Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea.
    Park HY; Hwang J; Kim DH; Jeon SM; Choi SH; Kwon JW
    BMC Cancer; 2020 Sep; 20(1):846. PubMed ID: 32883237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment.
    Sullivan DR; Forsberg CW; Ganzini L; Au DH; Gould MK; Provenzale D; Slatore CG
    J Clin Oncol; 2016 Nov; 34(33):3984-3991. PubMed ID: 27996350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of standardized allergen-removed Rhus verniciflua extract as maintenance therapy after first-line chemotherapy in patients with advanced non-small cell lung cancer.
    Lee J; Chae J; Lee S; Kim K; Eo W; Kim S; Choi W; Cheon SH
    Am J Chin Med; 2013; 41(4):773-87. PubMed ID: 23895151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.